Patent · US Active

Carrier immunoglobulins

US8734796B2 · kind B2 · utility

1Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2010
Grant dateMay 27, 2014
Priority date
Expiry dateDec 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.